BACKGROUND Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of
cancer therapy. The goal of this systematic review was to update the Multinational …

Abstract Changes in cancer incidence and mortality have been modest during the past
several decades, but the number of cancer survivors has almost tripled during the same …

Background This practical guideline is based on the current scientific ESPEN guidelines on
nutrition in cancer patients. Methods ESPEN guidelines have been shortened and …

Cancers are among the leading causes of morbidity and mortality worldwide, and the
number of new cases is expected to rise significantly over the next decades. At the same …

Mucositis research and treatment are a rapidly evolving field providing constant new
avenues of research and potential therapies. The MASCC/ISOO Mucositis Study Group …

Background Considerable progress has been made in our understanding of the biological
basis for cancer therapy-induced mucosal barrier injury (mucositis). The last formal review of …

Diarrhoea induced by chemotherapy in cancer patients is common, causes notable
morbidity and mortality, and is managed inconsistently. Previous management guidelines …

Oral mucositis is a common side-effect associated with conventional cancer therapy and has
also recently been reported in association with newly emerging cancer therapies. It is …

Ionizing radiation is commonly used to treat a number of malignancies. Although highly
effective and now more targeted, many patients suffer side effects. The number of cancer …

Chemotherapy-induced diarrhea (CID) is a common and often severe side effect
experienced by colorectal cancer (CRC) patients during their treatment. As chemotherapy …